SILVER SPRING, Md. (AP) _ United Therapeutics Corp. (UTHR) on Wednesday reported third-quarter profit of $106.5 million.
On a per-share basis, the Silver Spring, Maryland-based company said it had net income of $2.42. Earnings, adjusted for stock option expense and non-recurring costs, were $3.98 per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $3.49 per share.
The drugmaker posted revenue of $412.7 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $372.3 million.
United Therapeutics shares have fallen 18 percent since the beginning of the year. The stock has increased 1.5 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR